Name: SUPHA PHARMACHEM LIMITED Financial Filings and Reports
Creator: FinancialReports
License: https://financialreports.eu/terms/

Filings indexed 444 across all filing types

Latest filing 2021-10-08 Regulatory Filings

Country IN India

Listing BSE.NS 539561

About SUPHA PHARMACHEM LIMITED

https://www.remlife.com

Supha Pharmachem Limited specializes in the development, manufacture, and distribution of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The company maintains manufacturing facilities equipped to adhere to international quality standards and Good Manufacturing Practices (GMP). Its core operations involve complex chemical synthesis and process optimization to support various therapeutic categories within the pharmaceutical supply chain. Supha Pharmachem focuses on delivering high-purity chemical components to a global client base, leveraging its research and development capabilities to ensure product efficacy and regulatory compliance. The organization provides technical support and customized solutions for the production of essential medicinal compounds, serving as a strategic supplier for formulation manufacturers worldwide.

Recent filings

Filing	Released	Lang
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2021. Regulatory Filings	2021-10-08	English
E-Voting Result and Scrutinizer Report for the 32nd Annual General Meeting of the Company held on 30.09.2021 Regulatory Filings	2021-10-01	English
Outcome / Proceedings of 32nd Annual General Meeting held on September 30, 2021 Regulatory Filings	2021-09-30	English
Intimation of closure of Trading Window pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015. Regulatory Filings	2021-09-29	English
Announcement under Regulation 30(LODR)- Newspaper Publication after posting Annual Report. Regulatory Filings	2021-09-04	English
Regulation 34(1) Annual Report and Notice of AGM Regulatory Filings	2021-09-02	English

Browse filings by year

8 years

	ID	Filing	Released	Lang
2021 15 filings
	46646293	Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2021. Regulatory Filings	2021-10-08	English
	46646310	E-Voting Result and Scrutinizer Report for the 32nd Annual General Meeting of the Company held on 30.09.2021 Regulatory Filings	2021-10-01	English
	46646300	Outcome / Proceedings of 32nd Annual General Meeting held on September 30, 2021 Regulatory Filings	2021-09-30	English
	46646302	Intimation of closure of Trading Window pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015. Regulatory Filings	2021-09-29	English
	46646312	Announcement under Regulation 30(LODR)- Newspaper Publication after posting Annual Report. Regulatory Filings	2021-09-04	English
	46646331	Regulation 34(1) Annual Report and Notice of AGM Regulatory Filings	2021-09-02	English
	46646314	Announcement under Regulation 30(LODR) of Newspaper Advertisement for 32nd AGM Regulatory Filings	2021-09-01	English
	46646316	32nd Annual General Meeting (AGM) of the Company will be held on Thursday, 30th September, 2021 at 10.00 am through VC/OAVM. Book Closure: From Friday 24th September, 2021 .... Regulatory Filings	2021-08-30	English
	46646318	Intimation of 32nd Annual General Meeting scheduled to be held on Thursday, September 30, 2021. Regulatory Filings	2021-08-30	English
	46646321	Announcement under Regulation 30 (LODR) - Intimation of appointment of new RTA in place of Old RTA. Regulatory Filings	2021-08-21	English
	46646324	We wish to inform you that the company is in process of changing its existing Registrar and Share Transfer Agent(RTA) i.e. Beetal Financial & Computer Services Private Limited. .... Regulatory Filings	2021-07-28	English
	46646334	The Company has appointed Ms. Ashvini Dhuri (ICSI Membership No. 66051) as a Company Secretary & Compliance Officer of the Company w.e.f. 21.07.2021. Regulatory Filings	2021-07-21	English
	46646337	Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2021. Regulatory Filings	2021-07-20	English
	46646340	Newspaper Clippings for publication of Unaudited Financial Results for the quarter ended June 30, 2021. Regulatory Filings	2021-07-12	English
	46646344	Announcement under Regulation 30 (LODR)-Resignation of Company Secretary and Compliance Officer Regulatory Filings	2021-07-07	English

Page 21 of 30

Prev … 19 20 21 22 23 … Next

Market data

Market data not available

Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products

2,202 peers

Company	Ticker	Country	Sector
13260917 Canada Inc. Biotech developing oral small molecules to restore muscle s…	MSCL	CA	Manufacturing
1608557 Ontario Inc. Biopharmaceutical company dedicated to R&D, discovery, and …	OTROQ	CA	Manufacturing
3B BlackBio Dx Limited Develops molecular diagnostic kits for oncology, infectious…	3BBLACKBIO	IN	Manufacturing
3D Medicines Inc. Commercial-stage biopharma specializing in next-generation …	1244	HK	Manufacturing
3SBio Inc. Biopharmaceutical enterprise specializing in R&D, productio…	1530	KY	Manufacturing
4BASEBIO PLC Manufactures GMP-grade synthetic DNA for next-generation th…	4BB	GB	Manufacturing
4D Molecular Therapeutics, Inc. Develops genetic medicines using AAV vectors for ophthalmol…	FDMT	US	Manufacturing
4Front Ventures Corp. Vertically integrated cannabis operator managing cultivatio…	FFNT	CA	Manufacturing
4SC AG Biopharmaceutical company with no products under developmen…	VSC	DE	Manufacturing
60 DEGREES PHARMACEUTICALS, INC. Develops and commercializes medicines for infectious diseas…	SXTP	US	Manufacturing

Page 1 of 221

1 2 3 … Next

SUPHA PHARMACHEM LIMITED via the API

Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.

Get API access Read API reference

Base URLapi.financialreports.eu

Auth headerx-api-key

Company ID63672

Ticker539561

ISININE549S01036

Endpoints

most-used routes for this company

GET	/api/companies/63672/	Company identity, sector, listing, identifiers
GET	/api/filings/?company=63672	Paginated list of all filings (filterable by type, date, language)
GET	/api/filings/{id}/	Single filing — metadata, document URL, processing status
GET	/api/filings/{id}/markdown/	Filing content as Markdown (PDF → text/tables/figures)
GET	/api/isins/?company=63672	All ISINs registered to this company
GET	/api/filing-types/	Reference: every filing-type code + category

Full reference: API reference · OpenAPI schema

cURL

latest filings for SUPHA PHARMACHEM LIMITED

$ curl https://api.financialreports.eu/api/filings/?company=63672 \
    -H "x-api-key: $FR_API_KEY" \
    -H "Accept: application/json"

Python

requests

import requests

r = requests.get(
    "https://api.financialreports.eu/api/filings/",
    params={"company": 63672},
    headers={"x-api-key": API_KEY},
)
filings = r.json()["results"]

MCP server

Claude · Claude Code · ChatGPT

Claude setup ChatGPT setup Claude Code setup

// MCP server URL
https://mcp.financialfilings.com/mcp

// Once connected, the LLM can query this company directly:
"Pull the latest 5 filings for SUPHA PHARMACHEM LIMITED (id: 63672)"

SUPHA PHARMACHEM LIMITED — Investor Relations & Filings